MDT · ISSUER CIK 1613103
Medtronic plc
Between Aug 1, 2026 and Oct 29, 2026, 9 Medtronic plc insiders reported $0.00 of open-market purchases and $5.9M of sales on SEC Form 4.
↗9 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 2 of 3 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$5.9MInsider selling
−$5.9MNet open-market
Oct 21, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 202617:18 | Oct 15, 2026 | MDT | Director | J · OtherLate 6d | — | −182 | 9,977 | -2% | — | ||
| Oct 16, 202618:02 | Oct 15, 2026 | MDT | EVP, Pres MedSurg and Americas | S · Sell10b5-1 | $96.00 | −10,420 | 105,916 | -9% | −$1.0M | ||
| Oct 16, 202618:00 | Oct 15, 2026 | MDT | Chairman and CEO, Director | S · Sell10b5-1 | $95.00 | −50,000 | 277,866 | -15% | −$4.8M | ||
| Sep 17, 202616:17 | Sep 16, 2026 | MDT | EVP & President Cardiovascular | S · Sell | $93.65 | −1,483 | 42,186 | -3% | −$139K | ||
| Sep 16, 202616:16 | Sep 15, 2026 | MDT | Chief Accounting Officer | G · Gift | — | −600 | 16,398 | -4% | — | ||
| Aug 24, 202617:04 | Aug 20, 2026 | MDT | EVP, Pres MedSurg and Americas | F · Tax | $92.30 | −1,084 | 116,336 | -1% | $100K | ||
| Aug 4, 202620:00 | Jul 31, 2026 | MDT | Chief Accounting Officer | F · Tax | $85.39 | −212 | 14,661 | -1% | $18K | ||
| Aug 4, 202620:00 | Aug 3, 2026 | MDT | Chief Accounting Officer | A · Grant | — | +2,337 | 16,998 | +16% | — | ||
| Aug 4, 202620:00 | Jul 31, 2026 | MDT | SVP, Chief HR Officer | F · Tax | $85.39 | −1,675 | 34,159 | -5% | $143K | ||
| Aug 4, 202620:00 | Aug 3, 2026 | MDT | SVP, Chief HR Officer | A · Grant | — | +5,769 | 39,928 | +17% | — | ||
| Aug 4, 202619:59 | Jul 31, 2026 | MDT | EVP & President, Neuroscience | F · Tax | $85.39 | −1,739 | 28,467 | -6% | $148K | ||
| Aug 4, 202619:59 | Aug 3, 2026 | MDT | EVP & President, Neuroscience | A · Grant | — | +6,923 | 35,390 | +24% | — | ||
| Aug 4, 202619:59 | Aug 3, 2026 | MDT | EVP, GC and Secretary | A · Grant | — | +6,346 | 26,721 | +31% | — | ||
| Aug 4, 202619:59 | Aug 3, 2026 | MDT | EVP & Chief Financial Officer | A · Grant | — | +11,537 | 49,645 | +30% | — | ||
| Aug 4, 202619:58 | Jul 31, 2026 | MDT | EVP, Pres MedSurg and Americas | F · Tax | $85.39 | −3,356 | 60,313 | -5% | $287K | ||
| Aug 4, 202619:58 | Aug 3, 2026 | MDT | EVP, Pres MedSurg and Americas | A · Grant | — | +57,107 | 117,420 | +95% | — | ||
| Aug 4, 202619:58 | Jul 31, 2026 | MDT | EVP & President Cardiovascular | F · Tax | $85.39 | −3,074 | 34,439 | -8% | $262K | ||
| Aug 4, 202619:58 | Aug 3, 2026 | MDT | EVP & President Cardiovascular | A · Grant | — | +9,230 | 43,669 | +27% | — | ||
| Aug 4, 202619:57 | Jul 31, 2026 | MDT | Chairman and CEO, Director | F · Tax | $85.39 | −15,810 | 286,333 | -5% | $1.4M | ||
| Aug 4, 202619:57 | Aug 3, 2026 | MDT | Chairman and CEO, Director | A · Grant | — | +41,533 | 327,866 | +15% | — |